Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Ecolab's Eco-Flex Teat Dip To Boost Food & Beverage Segment

Published 02/09/2020, 08:35 PM
Updated 07/09/2023, 06:31 AM

Ecolab Inc. (NYSE:ECL) recently launched Eco-Flex Teat Dip, an udder care solution to prevent infection among dairy cows and ensure quality milk. This is naturally expected to boost Ecolab’s Food & Beverage business.

Available through Ecolab agricultural products distributors, Eco-Flex Teat Dip is a three-in-one solution that provides effective disinfection and protection for cows, and can also be used as a pre- and post-milking disinfectant and conditioner.

Thus, Eco-Flex can help dairy producers reduce costs of maintaining animal health and achieve milk quality goals.

Into Ecolab’s Food & Beverage Business

Ecolab’s Food & Beverage business provides a comprehensive set of solutions that help increase food safety and product quality. These include Dairy Farm Solutions, Worker Hygiene Solutions, Dairy Membrane Solutions, Environmental Cleaning Solutions, Fresh Produce Solutions and so on.

Some coveted products which significantly contribute to the segment’s revenues are — the 3D Trasar Technology, Quadexx Pro and Synergex Sanitizer and Disinfectant.

Market Prospects

Per Fortune Business Insights, the global agricultural biologicals market is projected to reach a worth of $20.59 billion, at a CAGR of 13.7%.

Hence, the latest move has been a well-timed one for Ecolab.

Share Price Performance

Over the past year, shares of this Zacks Rank #3 (Hold) company have rallied 28.4% compared with the industry’s 10.2% growth. The S&P 500 index has grown 21.9%.

Key Picks

Some better-ranked stocks in the broader medical space are AmerisourceBergen Corporation (NYSE:ABC) , Cardinal Health (NYSE:CAH) and DexCom, Inc. (NASDAQ:DXCM) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

AmerisourceBergen’s long-term earnings are expected to grow 7.4%.

Cardinal Health’s long-term earnings are projected to rise 6.2%.

DexCom’s first-quarter earnings are estimated to climb 220%.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Ecolab Inc. (ECL): Free Stock Analysis Report

Cardinal Health, Inc. (CAH): Free Stock Analysis Report

AmerisourceBergen Corporation (ABC): Free Stock Analysis Report

DexCom, Inc. (DXCM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.